<DOC>
	<DOC>NCT01823055</DOC>
	<brief_summary>To perform a clinical safety and efficacy assessment of the Uphold LITE system for pelvic organ prolapse in a prospective multicenter, single cohort study.</brief_summary>
	<brief_title>Safety and Efficacy of a Transvaginal Suture Capturing Mesh Device</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Cystocele</mesh_term>
	<mesh_term>Uterine Prolapse</mesh_term>
	<criteria>18 years of age or older and present with primary or recurrent prolapse of the middle vaginal compartment corresponding to stage 2 or higher (according to the Pelvic Organ Prolapse Quantification [POPQ] system)9, with or without anterior vaginal wall prolapse, and experiences symptoms of vaginal bulging with or without a previous hysterectomy being able to provide oral and written informed consent before entering the study. previous cancer of any pelvic organ, systemic glucocorticoid treatment, insulintreated diabetes, an inability to participate in study followup or to provide informed consent, or the need for any concomitant pelvic surgery.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>